FDA: Hospira recalls one lot of Magnesium Sulfate Injection

Editor's Note

The Food and Drug Administration (FDA) announced January 6 that Hospira, Inc (Lake Forest, Illinois) recalled one lot of Magnesium Sulfate in Water for Injection (0.325 mEq Mg⁺⁺/mL) 40 mg/mL 2g total, 50 mL (NDC: 0409-6729-24, Lot 53-113-JT, Expiry November 1, 2016).

The recall was initiated because of a confirmed customer report of an incorrect barcode on the primary bag labeling. The barcode on the overwrap is correct, but there is the potential for the primary container barcode to be mislabeled with Heparin Sodium 2000 USP Units/1000 mL in 0.9% Sodium Chloride Injection.

Posted 01/06/2016] AUDIENCE: Pharmacy ISSUE: Hospira, Inc. announced a voluntary recall of one lot of MAGNESIUM SULFATE IN WATER FOR INJECTION (0.325 mEq Mg**/mL) 40 mg/mL 2g total, 50 mL (NDC: 0409-6729-24, Lot 53-113-JT, Expiry 1NOV2016) to the user level due to a confirmed customer report of an incorrect barcode on the primary bag labeling.